Metrics as of 10/13/2026, 08:50 AM (Berlin time), refresh in progress.
Tonix Pharmaceuticals Holding Stock
Tonix Pharmaceuticals Holding Corp.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Seth Lederman
- Employees
- 142
- Market cap
- $102 M
- IPO
- 10/05/2012
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical firm primarily operating in the clinical development stage. Its overarching mission involves the discovery, acquisition, advancement, and commercialization of novel therapeutic agents and diagnostic tools, all aimed at combating human illnesses and easing…
Tonix Pharmaceuticals Holding stock: price history
1D
-3.8%
1W
-17.0%
1M
-46.2%
6M
-52.1%
YTD
-59.1%
1Y
-68.1%
2Y
-56.7%
5Y
-100.0%
10Y
-100.0%
Next earnings date
Next earnings date
09/11/2026 (in 23 days)
Volatility around earnings
~6% stronger price swings than usual
Ask the agents about Tonix Pharmaceuticals Holding
Analyst assessment of Tonix Pharmaceuticals Holding
PRICE TARGET LOW
US$27.00
CONSENSUS
US$27.00
MEDIAN
US$27.00
PRICE TARGET HIGH
US$27.00
0
STRONG BUY
6
BUY
1
HOLD
0
SELL
0
STRONG SELL
7
TOTAL · Buy
As of: 20/03/2025
Tonix Pharmaceuticals Holding stock metrics
P/E
-0.48
P/B
0.48
EV/EBITDA
0.46
RETURN ON EQUITY
-18.2%
NET MARGIN
-299.4%
DEBT/EQUITY
0.01
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.7%
FLOAT SHARES
15,888,880
AVG. DAILY VOLUME (30D)
613,798
Insider transactions (SEC)
LEDERMAN SETH
BAGGER RICHARD H
SAENGER BRADLEY
Taylor Carolyn E.
Stillwell Richard Newcomb
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Tonix Pharmaceuticals Holding stock
What does Tonix Pharmaceuticals Holding do?
Tonix Pharmaceuticals Holding Corp. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Seth Lederman, the company employs around 142 people.
The IPO was on 10/05/2012; the stock trades on NASDAQ under the ticker TNXP.
What do analysts say about Tonix Pharmaceuticals Holding stock?
7 analysts rate the stock, the consensus is Buy (as of 20/03/2025).
The average price target is US$27.00, ranging from US$27.00 to US$27.00, with a median of US$27.00.
This is an external assessment, not a statement by Market Jury.
When does Tonix Pharmaceuticals Holding report next?
The next earnings date is 09/11/2026.
Around past earnings, price swings were roughly 6% stronger than usual.
Does Tonix Pharmaceuticals Holding pay a dividend?
No, Tonix Pharmaceuticals Holding currently does not pay a dividend.
Which stocks are comparable to Tonix Pharmaceuticals Holding?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get Tonix Pharmaceuticals Holding stock analyzed?
Clicking "Analyze stock" lets five strategies assess Tonix Pharmaceuticals Holding against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.